Company
ztibio_img
Standard Radiopharmaceuticals for Theragnostic Oncology
Also known as ZTI BIOSCIENCES
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Daejeon, South Korea
- Founded
- 2020
Claim, correct or request removal
Record updated 28 September 2026
About
ZTI BIOSCIENCES, combining its very own original platform nanotechnology with biotech, is developing a next generation therapeutic radiopharmaceuticals for intractable & recurring solid cancers.
Products
- Other
- TERACARRIER
Loading relationship preview